Mark L. Ormiston, Ph.D.
Affiliations: | 2006 | Biomedical Engineering | University of Toronto, Toronto, ON, Canada |
Area:
BiomedicalGoogle:
"Mark Ormiston"Parents
Sign in to add mentor| David Courtman | grad student | 2006 | University of Toronto | |
| (The role of innate immunity in the pathogenesis and treatment of experimental pulmonary hypertension.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wu D, Jansen-van Vuuren RD, Dasgupta A, et al. (2024) Novel Drp1 GTPase Inhibitor, Drpitor1a: Efficacy in Pulmonary Hypertension. Hypertension (Dallas, Tex. : 1979) |
| Hilton LR, Rätsep MT, Vandenbroek MM, et al. (2022) Impaired IL (Interleukin)-15 Signaling via Loss Drives Natural Killer Cell Deficiency and Pulmonary Hypertension. Hypertension (Dallas, Tex. : 1979). 101161HYPERTENSIONAH |
| Cober ND, VandenBroek MM, Ormiston ML, et al. (2022) Evolving Concepts in Endothelial Pathobiology of Pulmonary Arterial Hypertension. Hypertension (Dallas, Tex. : 1979). 101161HYPERTENSIONAH |
| Theilmann AL, Hawke LG, Hilton LR, et al. (2020) Endothelial Loss Drives a Proliferative Response to BMP (Bone Morphogenetic Protein) 9 via Prolonged Canonical Signaling. Arteriosclerosis, Thrombosis, and Vascular Biology. ATVBAHA119313357 |
| MacKeil JL, Brzezinska P, Burke-Kleinman J, et al. (2019) Phosphodiesterase 3B (PDE3B) antagonizes the anti-angiogenic actions of PKA in human and murine endothelial cells. Cellular Signalling. 62: 109342 |
| Hilton LR, Ormiston ML. (2019) Legumain in Pulmonary Arterial Hypertension. Arteriosclerosis, Thrombosis, and Vascular Biology. 39: 536-537 |
| Karmouty-Quintana H, Guignabert C, Kwapiszewska G, et al. (2018) Editorial: Molecular Mechanisms in Pulmonary Hypertension and Right Ventricle Dysfunction. Frontiers in Physiology. 9: 1777 |
| Ratsep MT, Moore SD, Jafri S, et al. (2018) Spontaneous pulmonary hypertension in genetic mouse models of natural killer cell deficiency. American Journal of Physiology. Lung Cellular and Molecular Physiology |
| Ferrer E, Dunmore BJ, Hassan D, et al. (2018) A Potential Role for Exosomal TCTP Export in Vascular Remodeling in Pulmonary Arterial Hypertension. American Journal of Respiratory Cell and Molecular Biology |
| Thenappan T, Ormiston ML, Ryan JJ, et al. (2018) Pulmonary arterial hypertension: pathogenesis and clinical management. Bmj (Clinical Research Ed.). 360: j5492 |